These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 19937165)

  • 21. Critical care issues in management of high-grade lymphoma.
    Johnson JK; Sorensen E
    Crit Care Nurs Clin North Am; 2013 Dec; 25(4):447-57, v-vi. PubMed ID: 24267281
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Does the proliferation fraction help identify mature B cell lymphomas with double- and triple-hit translocations?
    Mationg-Kalaw E; Tan LH; Tay K; Lim ST; Tang T; Lee YY; Tan SY
    Histopathology; 2012 Dec; 61(6):1214-8. PubMed ID: 23171357
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Progression of follicular large cell lymphoma to Burkitt's lymphoma.
    Sham RL; Phatak P; Carignan J; Janas J; Olson JP
    Cancer; 1989 Feb; 63(4):700-2. PubMed ID: 2644011
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Aggressive B-cell lymphomas of gastrointestinal tract: a clinicopathologic analysis of 54 cases].
    Zhou J; Xia C; Shen Q; Yin H; Zhang X; Shi Q; Zhou X; Ma J
    Zhonghua Bing Li Xue Za Zhi; 2014 Jan; 43(1):8-14. PubMed ID: 24713242
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Low incidence of MYC/BCL2 double-hit in Burkitt lymphoma.
    Yoshida M; Ichikawa A; Miyoshi H; Kiyasu J; Kimura Y; Niino D; Ohshima K
    Pathol Int; 2015 Sep; 65(9):486-9. PubMed ID: 26182827
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Transformed follicular non-Hodgkin lymphoma.
    Casulo C; Burack WR; Friedberg JW
    Blood; 2015 Jan; 125(1):40-7. PubMed ID: 25499449
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Expression of Myc target gene mina53 in subtypes of human lymphoma.
    Teye K; Arima N; Nakamura Y; Sakamoto K; Sueoka E; Kimura H; Tsuneoka M
    Oncol Rep; 2007 Oct; 18(4):841-8. PubMed ID: 17786344
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Establishment and comprehensive analysis of a new human transformed follicular lymphoma B cell line, Tat-1.
    Denyssevych T; Lestou VS; Knesevich S; Robichaud M; Salski C; Tan R; Gascoyne RD; Horsman DE; Mayer LD
    Leukemia; 2002 Feb; 16(2):276-83. PubMed ID: 11840295
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Concurrent and Clonally Related Pediatric Follicular Lymphoma and Burkitt Lymphoma in a 5-Year-Old Boy.
    Shaver AC; Zimmerman D; Liu M; Vnencak-Jones C; Kim AS
    Lab Med; 2016 Feb; 47(1):43-7. PubMed ID: 26732781
    [TBL] [Abstract][Full Text] [Related]  

  • 30. MYC rearrangements in histologically progressed follicular lymphomas.
    Yano T; Jaffe ES; Longo DL; Raffeld M
    Blood; 1992 Aug; 80(3):758-67. PubMed ID: 1638027
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Molecular mechanisms of transcriptional control of bcl-2 and c-myc in follicular and transformed lymphoma.
    Arcinas M; Heckman CA; Mehew JW; Boxer LM
    Cancer Res; 2001 Jul; 61(13):5202-6. PubMed ID: 11431360
    [TBL] [Abstract][Full Text] [Related]  

  • 32. ID3 mutations are recurrent events in double-hit B-cell lymphomas.
    Gebauer N; Bernard V; Feller AC; Merz H
    Anticancer Res; 2013 Nov; 33(11):4771-8. PubMed ID: 24222112
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Acquisition of a t(11;14)(q13;q32) in clonal evolution in a follicular lymphoma with a t(14;18)(q32;q21) and t(3;22)(q27;q11.2).
    Koduru PR; Chen W; Garcia R; Fuda F
    Cancer Genet; 2015 Jun; 208(6):303-9. PubMed ID: 25953460
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Double-Hit and Triple-Hit Follicular Lymphoma.
    Ziemba JB; Wolf Z; Weinstock M; Asakrah S
    Am J Clin Pathol; 2020 Apr; 153(5):672-685. PubMed ID: 32112707
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Adult B-cell lymphomas with burkitt-like morphology are phenotypically and genotypically heterogeneous with aggressive clinical behavior.
    McClure RF; Remstein ED; Macon WR; Dewald GW; Habermann TM; Hoering A; Kurtin PJ
    Am J Surg Pathol; 2005 Dec; 29(12):1652-60. PubMed ID: 16327438
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Utility of immunohistochemistry with an antibody against MYC at the initial diagnosis of follicular lymphoma, grade 3A, for predicting a more aggressive clinical course: a case report and review of the literature.
    Ichikawa K; Aritaka N; Ogura K; Hosone M; Ota Y; Sato E; Komatsu N; Hirano T
    Int J Clin Exp Pathol; 2015; 8(6):7559-64. PubMed ID: 26261669
    [TBL] [Abstract][Full Text] [Related]  

  • 37. MYC-associated and double-hit lymphomas: a review of pathobiology, prognosis, and therapeutic approaches.
    Petrich AM; Nabhan C; Smith SM
    Cancer; 2014 Dec; 120(24):3884-95. PubMed ID: 25060588
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [MYC-associated B-cell lymphomas: pathophysiology and treatment].
    Nitta H
    Rinsho Ketsueki; 2019; 60(3):155-164. PubMed ID: 31068510
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinicopathological features of double-hit B-cell lymphomas with MYC and BCL2, BCL6 or CCND1 rearrangements.
    Yoshida M; Ichikawa A; Miyoshi H; Kiyasu J; Kimura Y; Arakawa F; Niino D; Ohshima K
    Pathol Int; 2015 Oct; 65(10):519-27. PubMed ID: 26224092
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Double-hit lymphoma demonstrating t(6;14;18)(p25;q32;q21), suggesting two independent dual-hit translocations, MYC/BCL-2 and IRF4/BCL-2.
    Tabata R; Yasumizu R; Tabata C; Kojima M
    J Clin Exp Hematop; 2013; 53(2):141-50. PubMed ID: 23995111
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.